Published date: 13 December 2024
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Vaccines - 33651600
Location of contract
United Kingdom
Value of contract
£0
Procurement reference
CF-2690900D0O000000rwimUAA
Published date
13 December 2024
Approach to market date
31 January 2025
Contract start date
1 October 2025
Contract end date
30 September 2029
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of a vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 11.5 million doses of vaccine. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
The opportunity is not split into lots.
About the buyer
Contact name
Chantal Jockel
Address
10 South Colonnade
London
E14 4PU
GB
Share this notice
Approach to market date: 31 January 2025
All content is available under the
